THETA
Live / Allowed — Approved for publication (as of 27 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99591519
- Mark type
- Stylized text
- Filed
- 13 Jan 2026
- Attorney of record
- Nicole Kinsley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Drug delivery agents consisting of antibodies or antibody fragments, sold as an integral component of pharmaceuticals; Antibodies and antibody fragments for therapeutic purposes; Antibody-drug conjugates for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Antibody fragment-drug conjugates for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Korsana Biosciences, Inc., Waltham, MA, US
Prosecution history
- 27 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 21 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 21 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 03 Mar 2026 — ASSIGNED TO EXAMINER
- 13 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 13 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Jan 2026 — NEW APPLICATION ENTERED